Moreover, VAV1 regulation was linked to experimental autoimmune arthritis and anti-CCP negative RA [48], while FCGR2A variation was associated with the response to anti-TNF therapy in RA and the presence of atherosclerotic plaques in carotid arteries [[49], [50], [51]]. The gene discussed is VAV1; the disease is rheumatoid arthritis.